Tag Archive for: targeted polyNaut nanovesicles

Vianautis

ViaNautis Bio welcomes SCI Ventures as new investor, expanding CNS portfolio into spinal cord injury

/in

Investment supports application of ViaNautis’ polyNaut® platform to regenerative therapies for spinal cord injury, where targeted delivery remains a huge barrier Adds a new high-value CNS indication and provides further validation of polyNaut® as a versatile platform for precise, non-viral delivery of genetic medicines Cambridge, UK – 9 September 2026 – ViaNautis Bio (“ViaNautis”), the […]

Read more
Vianautis

ViaNautis Bio to present its targeted polyNaut® nanovesicles (tPNVs) for the generation of in vivo CAR-T therapies at ASGCT Annual Meeting

/in

Targeted polyNaut® nanovesicles (tPNVs) are ViaNautis’ proprietary, polymer-based delivery platform for oligonucleotides enabling cell‑specific targeting through nanobody conjugation CD8 nanobody conjugated tPNVs are simple to manufacture and display high stability at 4°C CD8-tPNVs precisely target CD8-expressing immune cells in vitro and in vivo after intravenous or subcutaneous administration Cambridge, UK – 7 May, 2026  – […]

Read more
© Optimum Strategic Communications.